Atlas Trials

Immunome, Inc.

10 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Immunome, Inc.

RecordFirmDate
A Phase 1 Study of 177Lu-IM-3050 in Participants With Advanced Cancer (NCT07505771)Immunome, Inc.2026-06-19
A Phase 1 Study of IM-1617 in Participants With Advanced Cancer (NCT07578571)Immunome, Inc.2026-05-21
A Relative Bioavailability and Bioequivalence Study of Varegacestat in Healthy Participants (NCT07610005)Immunome, Inc.2026-05-21
A Varegacestat Hepatic Impairment Study (NCT06841315)Immunome, Inc.2025-03-07
A Phase 1 Study of IM-1021 in Participants With Advanced Cancer (NCT06823167)Immunome, Inc.2025-02-26
A Phase 1 Mass Balance Study of Varegacestat (NCT06845852)Immunome, Inc.2025-02-25
A Cardiac Liability Study of Varegacestat in Healthy Participants (NCT06855264)Immunome, Inc.2025-02-24
A Phase 1 Study to Examine the Effects of Itraconazole After Single Dose Administration of Varegacestat (AL102) to Healthy Participants (NCT06677996)Immunome, Inc.2024-11-11
IMM-BCP-01 in Mild to Moderate COVID-19 (NCT05429021)Immunome, Inc.2022-06-03
A Study of AL102 in Patients With Progressing Desmoid Tumors (NCT04871282)Immunome, Inc.2021-09-01

Track Immunome, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.